|Day's Range||55.64 - 56.26|
|52 Week Range||37.71 - 56.26|
|PE Ratio (TTM)||66.31|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Integra announced in February its intent to acquire Codman Neurosurgery from Johnson & Johnson.
Integra LifeSciences (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Global medical technology major, Integra LifeSciences Holdings Corporation (IART) recently inked an agreement with aap Implantate AG, a Berlin-based trauma product maker.